sog

Attacking cancer tumors with next generation CAR-T cell therapies

In 2017, the first immuno-oncology cell therapies, known as chimeric antigen receptor T cells, or CAR T, were approved by the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists